|
IL105325A
(en)
*
|
1992-04-16 |
1996-11-14 |
Minnesota Mining & Mfg |
Immunogen/vaccine adjuvant composition
|
|
EP0688205A1
(en)
*
|
1993-03-11 |
1995-12-27 |
Secretech, Inc. |
Polymeric mucoadhesives in the delivery of immunogens at mucosal surfaces
|
|
AU5543294A
(en)
*
|
1993-10-29 |
1995-05-22 |
Pharmos Corp. |
Submicron emulsions as vaccine adjuvants
|
|
US5961970A
(en)
*
|
1993-10-29 |
1999-10-05 |
Pharmos Corporation |
Submicron emulsions as vaccine adjuvants
|
|
GB9417742D0
(en)
*
|
1994-09-03 |
1994-10-19 |
Univ Nottingham |
Macrophage stimulating composition
|
|
BE1008977A5
(fr)
*
|
1994-12-27 |
1996-10-01 |
Solvay |
Adjuvants pour vaccins.
|
|
US5891393A
(en)
*
|
1996-04-09 |
1999-04-06 |
The University Of North Carolina At Chapel Hill |
Method for the microbial decontamination of blood platelets
|
|
GB9622159D0
(en)
*
|
1996-10-24 |
1996-12-18 |
Solvay Sociutu Anonyme |
Polyanionic polymers as adjuvants for mucosal immunization
|
|
US6197327B1
(en)
*
|
1997-06-11 |
2001-03-06 |
Umd, Inc. |
Device and method for treatment of dysmenorrhea
|
|
US6572874B1
(en)
|
1998-05-15 |
2003-06-03 |
Umd, Inc. |
Vaginal delivery of bisphosphonates
|
|
US6416779B1
(en)
|
1997-06-11 |
2002-07-09 |
Umd, Inc. |
Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
|
|
FR2775601B1
(fr)
|
1998-03-03 |
2001-09-21 |
Merial Sas |
Vaccins vivants recombines et adjuves
|
|
FR2776928B1
(fr)
*
|
1998-04-03 |
2000-06-23 |
Merial Sas |
Vaccins adn adjuves
|
|
WO2000056361A2
(en)
*
|
1999-03-24 |
2000-09-28 |
The Secretary Of State For Defence |
Vaccine composition
|
|
US6943152B1
(en)
*
|
1999-06-10 |
2005-09-13 |
Merial |
DNA vaccine-PCV
|
|
US7018638B2
(en)
|
2000-12-19 |
2006-03-28 |
Wyeth |
Mycoplasma hyopneumoniae bacterin vaccine
|
|
MY129765A
(en)
|
2000-12-19 |
2007-04-30 |
Wyeth Corp |
Improved mycoplasma hyopneumoniae bacterin vaccine
|
|
US6676958B2
(en)
*
|
2001-06-19 |
2004-01-13 |
Advanced Bioadjuvants, Llc |
Adjuvant composition for mucosal and injection delivered vaccines
|
|
EP1594524B1
(en)
|
2003-01-21 |
2012-08-15 |
Novartis Vaccines and Diagnostics, Inc. |
Use of tryptanthrin compounds for immune potentiation
|
|
EP2258365B1
(en)
|
2003-03-28 |
2013-05-29 |
Novartis Vaccines and Diagnostics, Inc. |
Use of organic compounds for immunopotentiation
|
|
CA2571421A1
(en)
|
2004-06-24 |
2006-01-05 |
Nicholas Valiante |
Compounds for immunopotentiation
|
|
WO2006115509A2
(en)
|
2004-06-24 |
2006-11-02 |
Novartis Vaccines And Diagnostics Inc. |
Small molecule immunopotentiators and assays for their detection
|
|
UA95602C2
(ru)
|
2004-12-30 |
2011-08-25 |
Берингер Ингельхейм Ветмедика, Инк. |
Иммуногенная композиция цвс2 и способы приготовления такой композиции
|
|
ES2470340T3
(es)
|
2005-12-28 |
2014-06-23 |
Advanced Bionutrition Corporation |
Vehículo de administración para bacterias probi�ticas que comprende una matriz seca de polisac�ridos, sac�ridos y polioles en forma vítrea
|
|
EP2275132B1
(en)
|
2005-12-29 |
2021-03-03 |
Boehringer Ingelheim Animal Health USA Inc. |
Multivalent PCV2 immunogenic compositions and methods of producing them
|
|
MX338626B
(es)
|
2005-12-29 |
2016-04-26 |
Boehringer Ingelheim Vetmed |
Uso de una composicion inmunogenica de pcv2 para producir los sintomas clinicos en cerdos.
|
|
US20100010217A1
(en)
*
|
2006-03-23 |
2010-01-14 |
Valiante Nicholas M |
Methods for the preparation of imidazole-containing compounds
|
|
EP2007765B1
(en)
*
|
2006-03-23 |
2012-06-27 |
Novartis AG |
Immunopotentiating compounds
|
|
WO2007109813A1
(en)
|
2006-03-23 |
2007-09-27 |
Novartis Ag |
Imidazoquinoxaline compounds as immunomodulators
|
|
EP2859900A1
(en)
|
2006-12-11 |
2015-04-15 |
Boehringer Ingelheim Vetmedica, Inc. |
Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
|
|
EP1941903A1
(en)
|
2007-01-03 |
2008-07-09 |
Boehringer Ingelheim Vetmedica Gmbh |
Prophylaxis and treatment of PRDC
|
|
EP1958644A1
(en)
|
2007-02-13 |
2008-08-20 |
Boehringer Ingelheim Vetmedica Gmbh |
Prevention and treatment of sub-clinical pcvd
|
|
US20080292663A1
(en)
*
|
2007-05-22 |
2008-11-27 |
Gerber Jay D |
Adjuvant compositions and methods for delivering vaccines
|
|
JP5613061B2
(ja)
|
2008-01-23 |
2014-10-22 |
ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド |
Ｐｃｖ２マイコプラズマ・ハイオニューモニエ免疫原性組成物および前記組成物の製造方法
|
|
AU2009333559B2
(en)
|
2008-12-09 |
2015-03-12 |
Gilead Sciences, Inc. |
Modulators of toll-like receptors
|
|
AU2010232180B2
(en)
*
|
2009-03-31 |
2016-09-22 |
Japan As Represented By The Director-General Of National Institute Of Infectious Diseases |
Method for prophylaxis of influenza using vaccine for intranasal administration
|
|
AU2010254235B2
(en)
|
2009-05-26 |
2015-04-02 |
Advanced Bionutrition Corporation |
Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
|
|
BR112012018839B1
(pt)
|
2010-01-28 |
2020-04-14 |
Advanced Bionutrition Corp |
composição vítrea seca compreendendo um material bioativo
|
|
US9504750B2
(en)
|
2010-01-28 |
2016-11-29 |
Advanced Bionutrition Corporation |
Stabilizing composition for biological materials
|
|
AU2013204906B2
(en)
|
2012-03-12 |
2016-01-07 |
Advanced Bioadjuvants, Llc |
Adjuvant and vaccine compositions
|
|
UA114503C2
(uk)
|
2012-04-04 |
2017-06-26 |
Зоетіс Сервісіз Ллс |
Комбінована вакцина pcv та mycoplasma hyopneumoniae
|
|
US9120859B2
(en)
|
2012-04-04 |
2015-09-01 |
Zoetis Services Llc |
Mycoplasma hyopneumoniae vaccine
|
|
UA114504C2
(uk)
|
2012-04-04 |
2017-06-26 |
Зоетіс Сервісіз Ллс |
Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
|
|
US9505808B2
(en)
|
2013-10-02 |
2016-11-29 |
Boehringer Ingelheim Vetmedica, Inc. |
PCV2 ORF2 protein variant and virus like particles composed thereof
|
|
WO2016001907A1
(en)
|
2014-07-02 |
2016-01-07 |
Prendergast Patrick T |
Mogroside iv and mogroside v as agonist/stimulator/un-blocking agent for toll-like receptor 4 and adjuvant for use in human/animal vaccine and to stimulate immunity against disease agents.
|
|
EP3328215B1
(en)
|
2015-07-29 |
2021-07-07 |
Advanced BioNutrition Corp. |
Stable dry probiotic compositions for special dietary uses
|
|
US12558395B2
(en)
|
2015-07-29 |
2026-02-24 |
Advanced Bionutrition Corp. |
Stable dry probiotic compositions for special dietary uses
|
|
JP7339285B2
(ja)
|
2018-06-04 |
2023-09-05 |
アプロス セラピューティクス， インコーポレイテッド |
Ｔｌｒ７ペプチドコンジュゲート
|
|
CA3103503A1
(en)
|
2018-07-02 |
2020-01-09 |
Ayuvis Research, Inc. |
Novel immunodulating small molecules
|